Feng Li

Associate Professor

Baylor College of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

MURUGESAN PALANIAPPAN

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Jeroen Pollet

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Sung Yun Jung

Associate Professor

Baylor College of Medicine

UNITED STATES

View details

Mirjana Maletic-Savatic

Associate Professor

Baylor College of Medicine

UNITED STATES

View details

John Faver

Relay Therapeutics Inc

UNITED STATES

View details

Choladda V. Curry

UNITED STATES

View details

Mingxing Teng

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Tiangang Li

Associate Professor

University of Oklahoma Health Sciences Center

UNITED STATES

View details

Wanqing Liu

Associate Professor

Wayne State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Feng Li

Research Interests

Explore related searches

Contact this professor

Articles (13)

CYP3A-Mediated Carbon–Carbon Bond Cleavages in Drug Metabolism

Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology

The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib

Small-molecule chemical probes for the potential therapeutic targets in alcoholic liver diseases☆

Identifying the Reactive Metabolites of Tyrosine Kinase Inhibitor Pexidartinib In Vitro Using LC–MS-Based Metabolomic Approaches

Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis

The roles of Cyp1a2 and Cyp2d in pharmacokinetic profiles of serotonin and norepinephrine reuptake inhibitor duloxetine and its metabolites in mice

Effects of apical sodium-bile acid transporter inhibitor and obeticholic acid co-treatment in experimental non-alcoholic steatohepatitis

Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections

DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M pro inhibitors

Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency

Discovery and characterization of bromodomain 2–specific inhibitors of BRDT

Metabolic profiling of norepinephrine reuptake inhibitor atomoxetine.

Collaborators (9)

MURUGESAN PALANIAPPAN

Jeroen Pollet

Sung Yun Jung

Mirjana Maletic-Savatic

John Faver

Choladda V. Curry

Mingxing Teng

Tiangang Li

Wanqing Liu

Make your next move.